PROX1 is a predictor of survival for gliomas WHO grade II
The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a tr...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 May 2011
|
| In: |
British journal of cancer
Year: 2011, Volume: 104, Issue: 11, Pages: 1747-1754 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/bjc.2011.162 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2011.162 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2011162 |
| Author Notes: | T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1800495706 | ||
| 003 | DE-627 | ||
| 005 | 20220820172554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220428s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/bjc.2011.162 |2 doi | |
| 035 | |a (DE-627)1800495706 | ||
| 035 | |a (DE-599)KXP1800495706 | ||
| 035 | |a (OCoLC)1341459064 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Elsir, Tamador |e VerfasserIn |0 (DE-588)1256382787 |0 (DE-627)1800496397 |4 aut | |
| 245 | 1 | 0 | |a PROX1 is a predictor of survival for gliomas WHO grade II |c T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits |
| 264 | 1 | |c 10 May 2011 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.04.2022 | ||
| 520 | |a The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a transcription factor that has a critical role in the development of various organs. PROX1 has been ascribed both oncogenic and tumour suppressive functions in human cancers. We have recently shown that PROX1 may act as a diagnostic marker for high-grade gliomas. The aim of this study was to address the prognostic value of PROX1 in grade II gliomas. | ||
| 650 | 4 | |a CNS cancer | |
| 650 | 4 | |a Prognostic markers | |
| 700 | 1 | |a Qu, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berntsson, S. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Orrego, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Olofsson, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lindström, M. S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nistér, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Hartmann, Christian |e VerfasserIn |0 (DE-588)1030180539 |0 (DE-627)734895240 |0 (DE-576)377991465 |4 aut | |
| 700 | 1 | |a Ribom, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Smits, A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1947 |g 104(2011), 11, Seite 1747-1754 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnas |a PROX1 is a predictor of survival for gliomas WHO grade II |
| 773 | 1 | 8 | |g volume:104 |g year:2011 |g number:11 |g pages:1747-1754 |g extent:8 |a PROX1 is a predictor of survival for gliomas WHO grade II |
| 856 | 4 | 0 | |u https://doi.org/10.1038/bjc.2011.162 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/bjc2011162 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220428 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1030180539 |a Hartmann, Christian |m 1030180539:Hartmann, Christian |d 50000 |e 50000PH1030180539 |k 0/50000/ |p 9 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 8 | ||
| 999 | |a KXP-PPN1800495706 |e 4125266794 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1800495706"],"doi":["10.1038/bjc.2011.162"]},"note":["Gesehen am 28.04.2022"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","display":"Elsir, Tamador","given":"Tamador","family":"Elsir"},{"given":"M.","family":"Qu","display":"Qu, M.","role":"aut"},{"role":"aut","display":"Berntsson, S. G.","given":"S. G.","family":"Berntsson"},{"family":"Orrego","given":"A.","role":"aut","display":"Orrego, A."},{"display":"Olofsson, T.","role":"aut","family":"Olofsson","given":"T."},{"role":"aut","display":"Lindström, M. S.","given":"M. S.","family":"Lindström"},{"given":"M.","family":"Nistér","display":"Nistér, M.","role":"aut"},{"family":"Deimling","given":"Andreas von","role":"aut","display":"Deimling, Andreas von"},{"display":"Hartmann, Christian","role":"aut","given":"Christian","family":"Hartmann"},{"given":"D.","family":"Ribom","role":"aut","display":"Ribom, D."},{"role":"aut","display":"Smits, A.","family":"Smits","given":"A."}],"title":[{"title":"PROX1 is a predictor of survival for gliomas WHO grade II","title_sort":"PROX1 is a predictor of survival for gliomas WHO grade II"}],"recId":"1800495706","physDesc":[{"extent":"8 S."}],"relHost":[{"recId":"320420094","origin":[{"dateIssuedKey":"1947","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedDisp":"1947-","publisherPlace":"Edinburgh ; Edinburgh"}],"part":{"extent":"8","pages":"1747-1754","volume":"104","issue":"11","text":"104(2011), 11, Seite 1747-1754","year":"2011"},"note":["Gesehen am 27.10.25"],"titleAlt":[{"title":"BJC"}],"title":[{"title_sort":"British journal of cancer","title":"British journal of cancer","subtitle":"BJC"}],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"PROX1 is a predictor of survival for gliomas WHO grade IIBritish journal of cancer","id":{"eki":["320420094"],"issn":["1532-1827"],"zdb":["2002452-6"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["T. Elsir, M. Qu, S.G. Berntsson, A. Orrego, T. Olofsson, M.S. Lindström, M. Nistér, A. von Deimling, C. Hartmann, D. Ribom and A. Smits"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"10 May 2011"}]} | ||
| SRT | |a ELSIRTAMADPROX1ISAPR1020 | ||